Cypress Capital, LLC Organon & Co. Transaction History
Cypress Capital, LLC
- $350 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding OGN
# of Institutions
809Shares Held
201MCall Options Held
1.53MPut Options Held
1.07M-
Black Rock Inc. New York, NY32.6MShares$526 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.4MShares$490 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.2MShares$180 Million0.41% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.9MShares$160 Million0.05% of portfolio
-
State Street Corp Boston, MA9.34MShares$151 Million0.01% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $4.1B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...